ArticleThe American journal of gastroenterology2012

Optimum ribavirin exposure overcomes racial disparity in efficacy of peginterferon and ribavirin treatment for hepatitis C genotype 1.

Runyan Jin et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.